GORMAN KEVIN CHARLES bought NBIX
February 13, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 2,312 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $100.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,312
Price
$43.24
Total value
$100.0K
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 13, 2024
Filing dateFebruary 14, 2024
Shares owned after512,052
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.; 491,365 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.